Systemic treatments for high-risk localized prostate cancer-Reference-Cited by-同舟云学术

Systemic treatments for high-risk localized prostate cancer

Published:2018-05-15 Issue:8 Volume:15 Page:498-510
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Pignot Géraldine,Maillet Denis,Gross Emmanuel,Barthelemy Philippe,Beauval Jean-Baptiste,Constans-Schlurmann Friederike,Loriot Yohann,Ploussard Guillaume,Sargos Paul,Timsit Marc-Olivier,Vincendeau Sébastien,Pasticier Gilles,Borchiellini Delphine

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/s41585-018-0017-x.pdf

Reference120 articles.

1. Winter, A. et al. Comparison of prostate cancer survival in Germany and the United States: can differences be attributed to differences in stage distributions? BJU Int. 119, 550–559 (2016).

2. D’Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969–974 (1998).

3. Cooperberg, M. R., Broering, J. M. & Carroll, P. R. Time trends and local variation in primary treatment of localized prostate cancer. J. Clin. Oncol. 28, 1117–1123 (2010).

4. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

5. Patrikidou, A. et al. Who dies from prostate cancer? Prostate Cancer Prostatic Dis. 17, 348–352 (2014).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy;Biomacromolecules;2024-05-23

2. Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy;Science Advances;2024-02-02

3. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue;Cell & Bioscience;2023-03-20

4. Radiation therapy post radical prostatectomy: who, when and why?;Current Opinion in Supportive & Palliative Care;2023-01-20

5. Research Progress of Nano-drug Delivery System in Prostate Cancer br;PROG BIOCHEM BIOPHYS;2022